BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10903840)

  • 1. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
    Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
    Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.
    He J; Navarrete S; Jasinski M; Vulliamy T; Dokal I; Bessler M; Mason PJ
    Oncogene; 2002 Oct; 21(50):7740-4. PubMed ID: 12400016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning, genomic structure, and expression analysis of the mouse transcriptional intermediary factor 1 gamma gene.
    Yan KP; Dollé P; Mark M; Lerouge T; Wendling O; Chambon P; Losson R
    Gene; 2004 Jun; 334():3-13. PubMed ID: 15256250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human TruB family of pseudouridine synthase genes, including the Dyskeratosis Congenita 1 gene and the novel member TRUB1.
    Zucchini C; Strippoli P; Biolchi A; Solmi R; Lenzi L; D'Addabbo P; Carinci P; Valvassori L
    Int J Mol Med; 2003 Jun; 11(6):697-704. PubMed ID: 12736709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J; Dokal I
    Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One novel and two recurrent missense DKC1 mutations in patients with dyskeratosis congenita (DKC).
    Heiss NS; Mégarbané A; Klauck SM; Kreuz FR; Makhoul E; Majewski F; Poustka A
    Genet Couns; 2001; 12(2):129-36. PubMed ID: 11491307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping and characterization of the X-linked dyskeratosis congenita (DKC) gene.
    Hassock S; Vetrie D; Giannelli F
    Genomics; 1999 Jan; 55(1):21-7. PubMed ID: 9888995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
    Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
    Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense mutation in a patient with X-linked dyskeratosis congenita.
    Kraemer DM; Goebeler M
    Haematologica; 2003 Apr; 88(4):ECR11. PubMed ID: 12681984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskeratosis congenita.
    Handley TP; McCaul JA; Ogden GR
    Oral Oncol; 2006 Apr; 42(4):331-6. PubMed ID: 16140563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.
    Montanaro L; Brigotti M; Clohessy J; Barbieri S; Ceccarelli C; Santini D; Taffurelli M; Calienni M; Teruya-Feldstein J; Trerè D; Pandolfi PP; Derenzini M
    J Pathol; 2006 Sep; 210(1):10-8. PubMed ID: 16841302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome.
    Yaghmai R; Kimyai-Asadi A; Rostamiani K; Heiss NS; Poustka A; Eyaid W; Bodurtha J; Nousari HC; Hamosh A; Metzenberg A
    J Pediatr; 2000 Mar; 136(3):390-3. PubMed ID: 10700698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita.
    Hiramatsu H; Fujii T; Kitoh T; Sawada M; Osaka M; Koami K; Irino T; Miyajima T; Ito M; Sugiyama T; Okuno T
    Pediatr Hematol Oncol; 2002 Sep; 19(6):413-9. PubMed ID: 12186364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene.
    Lin Z; Carney G; Rizzo WB
    Mol Genet Metab; 2000 Nov; 71(3):496-505. PubMed ID: 11073717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.